Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesSurgical management of metastatic bone disease
Journal of Bone and Joint Surgery, 06/03/09
Bickels J et al. - In a review of the surgical management of metastatic bone disease, it was concluded that detailed preoperative evaluation is required to assess the local extent of bone destruction and soft-tissue involvement, involvement of other skeletal sites, and overall medical and oncological status.
Methods- Metastatic bone disease is a major contributor to the deterioration of quality of life of pts with cancer.
- It causes pain, impending and actual pathological fractures, and loss of function and may be associated with considerable metabolic alterations.
- Operative treatment may be required for an impending or existing fracture and intractable pain.
- Goals of surgery are to provide local tumor control and allow immediate weight-bearing and function.
- Radiation therapy is often indicated postoperatively.
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI
The Journal of Nuclear Medicine, 08/19/09
Endoprosthetic proximal femur replacement: Metastatic versus primary tumors
Surgical Oncology, 11/05/09
Loss of p16INK4, alone and with overexpression of osteopontin, correlates with survival of patients with spinal metastasis from hepatocellular carcinoma
Medical Oncology, 10/19/09
Article Search
Sponsor